Archive for
June, 2009
Monday, June 29th, 2009
Since Med Ad News' diabetes therapeutic feature was published last month, questions regarding the safety of insulin analogues such as the insulin glargine Lantus have surfaced. Now diabetes drug marketers Sanofi-Aventis SA and Novo Nordisk AS are engaged in rapid-fire PR initiatives to back the clinical evidence of their products.
On ...
Posted in
Adwise, DTC advertising, Legal actions, Magazine production, Patient education, Professional education, R&D Directions, e-Marketing |
No Comments »
Monday, June 29th, 2009
With the reduction in the number of representatives, the shift to specialty products, and the increasing barriers to physician access, the number of opportunities to influence physicians is plummeting. Every call must be high impact. As a result, pre-call planning has become a fundamental skill for successful pharmaceutical sales calls ...
Posted in
Sales force effectiveness |
No Comments »
Thursday, June 25th, 2009
A focus on specialty and biopharmaceutical companies and niche brands that treat serious and chronic conditions is paying off for Compass Healthcare Communications. Compass finds that specialty and biopharmaceutical companies and brands are more aggressive and entrepreneurial regarding innovative and cutting-edge programs.
Following the launch of pku.com, a community support Website ...
Posted in
DTC advertising, Patient education, Technology, Uncategorized, blogs |
1 Comment »
Wednesday, June 24th, 2009
In a rare show of solidarity, both innovative and generic pharmaceutical companies are stacking the barricades in response to sharp criticism of generic licensing agreements by the chairman of the Federal Trade Commission. Accusing new FTC chairman Jon Leibowitz of both fuzzy assumptions and unwarranted conclusions, the leaders of the ...
Posted in
Sales & Marketing |
No Comments »
Tuesday, June 23rd, 2009
Prevention may never overthrow treatment, but healthcare-focused companies and their advertising agencies are mindful of the wellness trend. Public opinion favors prevention as the most important healthcare reform priority, and Americans overwhelmingly support increasing funding for prevention programs to reduce disease and keep people healthy. Now, healthcare-focused marketing and advertising ...
Posted in
DTC advertising, Economy, Legal actions, Magazine production, Patient education, Technology, e-Marketing |
No Comments »
Tuesday, June 23rd, 2009
As referenced in an earlier post, the pharmaceutical industry appears to have let its market data go stale in recent months, neglecting to update its market research as a way to cut costs. Of course, it’s never just that simple. Marketers basically do two types of research. One is regular ...
Posted in
Sales & Marketing |
No Comments »
Tuesday, June 23rd, 2009
In case you've been under a rock lately, Rep. Charles Rangel, D-N.Y., chairman of the House Ways and Means Committee, proposed last week eliminating the tax deduction for prescription drug advertising. Mr. Rangel believes that this could bring in $37 billion that could go towards the costs of healthcare ...
Posted in
Uncategorized |
No Comments »
Tuesday, June 16th, 2009
Pharma CRM and data solutions provider Cegedim Dendrite took its show on the road today, holding its U.S. Roadshow at The New York Palace in NYC. The event was designed to highlight the company's continued financial stability and its success in 2008. The company, which is the product of the ...
Posted in
Sales & Marketing |
No Comments »
Tuesday, June 16th, 2009
Med Ad News’ interest in pharmaceutical advertising agencies’ philanthropic activities has grown since creating the Heart Award in 2009. Juice Pharma Worldwide reached out to share their recent project-oriented philanthropic involvement with Little Flower Children and Family Services of New York and additional pro-bono advertising plans for the future.
In May, ...
Posted in
Adwise, DTC advertising, Legal actions, Magazine production, Manny Awards, Med Ad News, Pro bono, e-Marketing |
No Comments »
Wednesday, June 10th, 2009
Recently, FDA issued a draft guidance titled Presenting Risk Information in Prescription Drug and Medical Device Promotion. The draft guidance outlines factors FDA considers when evaluating ads and labeling for prescription drugs, providing examples to illustrate the agency’s thinking. According to FDA, the guidance was issued in response to requests ...
Posted in
FDA Files, Sales & Marketing |
1 Comment »
|
|
